|View printer-friendly version|
|BrainStorm Cell Therapeutics Appoints Senior Kite Executive, Anthony Polverino, Ph.D., to Board of Directors|
"We are honored to have Dr. Polverino join our board of directors," said
Dr. Polverino is currently the interim chief scientific officer of Kite (now a wholly-owned subsidiary of
"I am excited to have the opportunity to join Brainstorm's board of directors," said Dr. Polverino. "Brainstorm is developing innovative treatments for patients with neurodegenerative diseases and I look forward to providing scientific and business guidance to the company."